Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injury
Persephoni backs SelSym Biotech to bring the first shelf-stable, blood-type agnostic hemostatic therapy to the point of injury, expanding trauma access.
-
Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth
-
호주 아들레이드, July 10, 2026 (GLOBE NEWSWIRE) -- 호주에 본사를 둔 글로벌 임상시험수탁기관(CRO)인 아반스 클리니컬(Avance Clinical)은 7월 15일부터 19일까지 대만 타이베이 난강전시센터(Taipei Nangang Exhibition Center, TaiNEX)에서 열리는 'BIO Asia–Taiwan...
-
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
-
Analyzes emerging technologies, patent activity & competitive developments shaping next generation of decentralized, highly automated manufacturing systems
-
Proposed acquisition of Kneat by Thoma Bravo provides significant, immediate, and certain value to shareholders after months-long strategic review process
-
Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio
-
The First Agentic Operating System for Life Sciences R&D PRESS RELEASE Already running NVIDIA BioNeMo in production, the SigmaticOS now leverages NVIDIA’s latest agentic innovations to connect...
-
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
-
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026